Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68 labeled PSMA-targeting radiodiagnostic agent HRS-9815

A radioconjugate composed of a human prostate specific membrane antigen (PSMA)-targeting agent labeled with the radioisotope gallium Ga 68, with potential use as a tracer for PSMA-expressing tumors during positron emission tomography (PET)/computed tomography (CT)). Upon intravenous administration, gallium Ga 68 labeled PSMA-targeting radiodiagnostic agent HRS-9815 targets and binds to PSMA-expressing tumor cells. Upon binding, PSMA-expressing tumor cells can be detected during PET/CT imaging. PSMA, a tumor-associated antigen (TAA) and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells as well as a variety of other solid tumors.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:HRS 9815
HRS-9815
HRS9815
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search